aod9604 academic study AOD 9604 10mg - Research Peptide purity research formula manufactured in the USA AOD-9604 Peptide | USA Made

Human trials limited: Clinical data shows modest or inconsistent results. Unclear mechanisms in humans: Translation from animals to people remains uncertain

The evidence reality There is no robust, high-quality human outcomes literature showing that adding AOD-9604 to semaglutide or tirzepatide produces clinically meaningful additional fat loss beyond what GLP-1/GIP therapy already achieves

Not for human consumption, therapeutic, diagnostic or veterinary use

This difference was achieved without any change in food intake, suggesting the weight loss came from metabolic changes rather than appetite suppression

A basic spreadsheet or notebook tracking: daily dose and time, weekly weight, bi-weekly measurements, and subjective notes provides sufficient data without excessive burden

The net effect: you're burning more fat and storing less